| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.70B | 42.25B | 36.58B | 20.35B | 15.10B | 14.76B |
| Gross Profit | 17.45B | 20.85B | 19.83B | 11.24B | 8.46B | 8.04B |
| EBITDA | 10.82B | 13.30B | 12.31B | 4.70B | 2.12B | 1.66B |
| Net Income | 7.06B | 8.72B | 8.59B | 3.14B | 1.86B | 807.02M |
Balance Sheet | ||||||
| Total Assets | 91.85B | 87.00B | 83.96B | 63.92B | 60.14B | 57.96B |
| Cash, Cash Equivalents and Short-Term Investments | 37.78B | 36.72B | 29.70B | 23.05B | 26.35B | 23.58B |
| Total Debt | 625.14M | 544.58M | 529.33M | 563.27M | 806.80M | 1.10B |
| Total Liabilities | 8.59B | 8.77B | 12.70B | 7.62B | 5.89B | 5.66B |
| Stockholders Equity | 83.26B | 78.23B | 71.25B | 56.31B | 54.24B | 52.30B |
Cash Flow | ||||||
| Free Cash Flow | 7.55B | 9.81B | 5.11B | -839.17M | 1.59B | 2.50B |
| Operating Cash Flow | 8.37B | 10.65B | 6.45B | 943.99M | 3.57B | 2.60B |
| Investing Cash Flow | -182.67M | -558.62M | -1.64B | -2.11B | 423.98M | -590.49M |
| Financing Cash Flow | -2.79B | -3.07B | 1.81B | -2.16B | -1.30B | -1.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥53.54B | 7.77 | ― | 4.70% | -25.28% | -24.84% | |
78 Outperform | ¥162.76B | 14.48 | ― | 1.78% | 4.04% | 4.80% | |
66 Neutral | ¥21.65B | 7.10 | ― | 0.76% | 20.69% | 17.46% | |
63 Neutral | ¥405.08B | 21.16 | 10.65% | 1.64% | 14.75% | 22.10% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥6.26B | 12.92 | ― | 2.41% | <0.01% | 23.81% | |
42 Neutral | ¥53.85B | -0.27 | -78.01% | ― | -14.08% | 54.85% |